Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.60 0.00 (0.00%)
As of 08/8/2025

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.60
$0.60
50-Day Range
$0.48
$0.67
52-Week Range
$0.31
$0.67
Volume
N/A
Average Volume
8,051 shs
Market Capitalization
$13.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PBSV Pharma-Bio Serv, Inc. - Seeking Alpha
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
PBSV Decisions Paying Off
PBSV Returns to Growth
PBSV Released Earnings and Declares Dividend
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.5499 on January 1st, 2025. Since then, PBSV shares have increased by 9.1% and is now trading at $0.60.

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) posted its earnings results on Monday, March, 17th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.35. The firm had revenue of $2.47 million for the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative trailing twelve-month return on equity of 1.47% and a negative net margin of 1.96%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Last Earnings
3/17/2025
Today
8/10/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consulting
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
CIK
1304161
Employees
185
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
5.45
P/E Growth
N/A
Net Income
-$780 thousand
Net Margins
-1.96%
Pretax Margin
-2.01%
Return on Equity
-1.47%
Return on Assets
-1.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.54
Quick Ratio
7.54

Sales & Book Value

Annual Sales
$9.51 million
Price / Sales
1.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
1.00

Miscellaneous

Outstanding Shares
22,930,000
Free Float
20,043,000
Market Cap
$13.76 million
Optionable
Not Optionable
Beta
0.64

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners